MDwise is focusing on medication by adding Medication Therapy Management Part D functionality in the Jiva population health platform from ZeOmega.
The move means the 1,400-plus providers in MDwise's network can now access Jiva to better understand the medications patients are being prescribed, assess their drug therapy adherence, and make necessary adjustments to improve medication safety.
This is especially important for more than 360,000 elderly, low-income, youth, and other vulnerable populations served by MDwise plans such as Hoosier Healthwise, Healthy Indiana Plan, and Hoosier Care Connect.
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli